YMAB 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with ...
San Francisco, California--(Newsfile Corp. - March 12, 2023) - Hagens Berman urges Y-mAbs Therapeutics, Inc. YMAB investors who suffered significant losses to submit your losses now. Class Period: Oct. 6, 2020 - Oct. 28, 2022 Lead Plaintiff Deadline: Mar. …